2022- 2023
- Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
- Non-Inflammatory Pain in Inflammatory Arthritis.
- Novel clusters of multimorbidity in people with eczema and asthma: a UK population-based data-driven cluster analysis.
- Estimating the contribution of respiratory pathogens to acute exacerbations of COPD using routine data.
- Patterns of healthcare resource utilisation of critical care survivors between 2006 and 2017 in Wales: a population- based study Journal of Clinical Medicine.
- Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study.
- Understanding the multimorbidity concept: effect of number and selection of conditions on multimorbidity prevalence in a large primary care population dataset.
- COVID-19 Booster Vaccination Uptake and Infection Breakthrough Amongst Health Care Workers in Wales: A national prospective cohort study.
- Did the UK’s public health Shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales?
- Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab.
- Severe COVID-19 outcomes post full vaccination of primary schedule and boosters: A meta-analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland and Wales.
- Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK).
- Risk of adverse clotting and bleeding following first and second doses of ChAdOx1 and BNT162b2: A self-controlled case series analysis in Wales.
- Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or SARS-CoV-2 infection: A national cohort study using linked electronic health records.
- Identifying unmet anti-thrombotic therapeutic need, and implications for stroke and systemic embolism in patients with atrial fibrillation: a population-scale longitudinal study.
- Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
- Age, sex, and socioeconomic differences in multimorbidity measured in four ways: UK primary care population analysis.
- Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
- The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data.
- Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people
- Real-world use of an etanercept biosimilar including selective versus automatic substitution in inflammatory arthritis patients: a UK-based electronic health records study
- Hughes abdominal closure versus standard mass closure to reduce incisional hernias following surgery for colorectal cancer: the HART RCT.
- Exploring the health impacts and inequalities of the new way of working: findings from a cross-sectional study.
- SARS-CoV-2 infection risk among 77,587 healthcare workers: a national observational longitudinal cohort study in Wales, United Kingdom, April to November 2020.
- Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality.
- Exploring gender differences, medical history, and treatments used in patients with fibromyalgia in the UK using primary-care data: a retrospective, population-based, cohort study.
- The epidemiology, healthcare and societal burden of basal cell carcinoma in Wales 2000-2018, a retrospective population-scale analysis
2021- 2022
- Good work in the COVID-19 recovery: priorities and changes for the future medRxiv
- Do home adaptation interventions help to reduce emergency fall admissions? A national longitudinal data-linkage study of 657,536 older adults living in Wales (UK) between 2010 and 2017.
- Health checks for adults with intellectual disability and association with survival rates: a linked electronic records matched cohort study in Wales, UK. BMJ Open.
- Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines. RMD Open.
- Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination. Clin Exp Rheumatol.
- Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UK.
- Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritis.
- Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al.
- Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data.
- The impact of behavioural risk factors on communicable diseases: a systematic review of reviews
- Anti-inflammatory and immunoregulatory effects of pinolenic acid in rheumatoid’ arthritis.
- Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventions
- Trust and Public Health Emergency Events: A Mixed-Methods Systematic Review
- Predicting a diagnosis of ankylosing spondylitis using primary care health records – a machine learning approach
- Digital Overuse and Addictive Traits and Their Relationship With Mental Well-Being and Socio-Demographic Factors: A National Population Survey for Wales
- Vaccinated Care Home Residents: A national observational longitudinal cohort study in Wales, United Kingdom, December 2020 to March 2021
- Intensity of COVID-19 in care homes following Hospital Discharge in the early stage of the UK epidemic
- The impact of a physician–critical care practitioner pre-hospital service in Wales on trauma survival: a retrospective analysis of linked registry data.
2019 -2020
- Gwerthuso proses system meddal i allan o roi organau, a weithredir gan nyrsys arbenigol yng Nghymru.
- Cynllunio astudiaeth gyd-gynhyrchu i oresgyn heriau methodolegol hysbys mewn ymchwil i roi organau, gydag aelodau teulu mewn profedigaeth.
- Effaith tymor byr cyflwyno system optio allan o roi organau yng Nghymru: astudiaeth cyn ac ar ôl cyflwyno.
- Mynediad arhydol i fannau gwyrdd a glas ac iechyd meddwl a lles unigolion: protocol ar gyfer arbrawf arhydol naturiol, ar draws y boblogaeth, yn gysylltiedig â chofnodion.
- Prosiect ELAStic (Astudiaeth Arhydol Electronig o Alcohol mewn Cymunedau).
- Lleihau effaith lludded arthritis: prawf a reolir ar hap am ddwy flynedd o ddulliau ymddygiadol gwybyddol gandimau rhiwmatoleg (RAFT).
- Effeithiau glwcocorticoidau cydredol mewn TOZURA, rhaglen astudio fframwaith cyffredinol o tocilizumab isgroenol mewn arthritis gwynegol.
- Gwerthusiad dulliau cymysg yn cymharu effaith dau ddull ymwybyddiaeth ofalgar o drin straen, gorbryder ac iselder ymhlith athrawon ysgol.
- Effeithiolrwydd cymharol secukinumab ac etanercept mewn cleifion sy’n naïf yn fiolegol sydd ag arthritis psoriatig a asesir drwy gymhariaeth anuniongyrchol a addaswyd mewn modd tebyg.
- AxSpA i gleifion sydd hefyd yn bodloni’r meini prawf ar gyfer fibromyalgia: nodi clystyrau amlwg o gleifion gan ddefnyddio data o gofrestr genedlaethol y DU (BSRBR-AS).
- Mesur poen mewn clefydau rhiwmatig a chyhyresgerbydol: y ffordd ymlaen? Adroddiad gan Grŵp Diddordeb Arbennig yn OMERACT 2018.
- Mae arwyddion cellog a moleciwlaidd synofaidd yn haenu ymateb clinigol i therapi csDMARD ac yn rhagweld dilyniant radiograffig mewn cleifion ag arthritis gwynegol cynnar.
- Gwerthusiad o effeithiolrwydd a diogelwch therapi cyfuniad sarilumab mewn cleifion ag arthritis gwynegol gydag ymateb annigonol i gyffuriau gwrth-rhiwmatig confensiynol sy’n addasu clefydau neu atalyddion ffactor necrosis tiwmor α: adolygiad llenyddiaeth systematig a meta-ddadansoddiadau rhwydwaith.
- Effaith triniaeth gyda gwrthfiotigau ar ganlyniadau ymhlith dynion hŷn yr amheuir bod ganddynt haint yn y llwybr wrinol: astudiaeth garfan ôl-weithredol.
- Profi rhagdybiaethau’r dangosydd Angen Obstetrig heb ei Gyflawni yn Ghana: Astudiaeth groesdoriadol o ddata cyflenwi cysylltiedig wedi’i seilio ar boblogaethau ac ysbytai.
- Poen niwropathig mewn arthritis soriatig: tystiolaeth o brosesu poen annormal.
- Dewis o therapi gwrthfiotig empirig a chanlyniadau anffafriol mewn oedolion hŷn yr amheuir eu bod yn dioddef o glefyd y llwybr wrinol: astudiaeth carfan.
- Pam fod cleifion a rhoddwyr gofal teuluol yn gwerthfawrogi gofal hosbis? Arolwg systematig o astudiaethau cymysg.
- Dadansoddiad o gynnwys cyfryngol o gyflwyno system “optio-allan ysgafn” o roi organau yng Nghymru 2015-17.
- Effeithiau concomitant glucocorticoids mewn TOZURA, rhaglen astudio fframwaith-cyffredin o tocilizumab isgroen mewn arthritis gwynegol
- Yr angen am ddata cymharol yn spondyloarthritis.
- Dylanwad ffibromyalgia cydafiach ar fesurau gweithgaredd afiechydon ac ymateb i atalyddion ffactor tiwmor necrosis mewn arthritis spondylo echelinol.
- Cyfathrebu Risg mewn Argyfwng: Y Gwersi a Ddysgwyd o Adolygiad Cyflym o Lenyddiaeth Lwyd ddiweddar ar Ebola, Zika a’r dwymyn felen.
- Mae ffactorau risg cardiofasgwlaidd sy’n rhagweld digwyddiadau cardiaidd yn wahanol mewn cleifion ag arthritis gwynegol, arthritis psoriatig, a psorïasis.
- Effaith ar iechyd a gwerth Economaidd o fodloni safonau ansawdd tai; astudiaeth wrtholygol hyderol cysylltedd data.
- Adnabod cleifion sydd â syndrom gorgyffwrdd clefyd rhwystrol asthma-cronig yr ysgyfaint gan ddefnyddio dadansoddiad dosbarth cudd o ddata cofnodion iechyd electronig: protocol astudiaeth.
- Derbyniadau argyfwng i ysbytai yn gysylltiedig ag ymyrraeth tai nad yw ar hap i fodloni safonau ansawdd tai cenedlaethol: astudiaeth hydredol cysylltu data.
- Y cysylltiad rhwng newidiadau mewn ffordd o fyw a marwolaethau o bob achos: yr Arolwg Iechyd a Ffordd o Fyw.
- Newidiadau mewn ymddygiad iechyd a hirhoedledd.
- Anghydraddoldeb economaidd-gymdeithasol o ran dal ati i gymryd meddyginiaeth ar gyfer cymorth ataliol cynradd a chymorth ataliol eilaidd i drin clefyd coronaidd y galon – astudiaeth carfan electronig o’r boblogaeth gyfan.
- Argymhellion EULAR ynghylch rheoli ffibromyalgia.
- Effeithiolrwydd a diogelwch biosimilar ABP 501 o’i gymharu ag adalimumab gyda chleifion sydd ag arthritis gwynegol cymedrol i ddifrifol: astudiaeth ar hap, dwbl-ddall, cyfwerth â chyfnod III.
- Trin Arthritis Gwynegol gyda Ffactor Necrosis Gwrth-Diwmor neu Therapi Tocilizumab fel Cyfrwng Biolegol Cyntaf mewn Astudiaeth Gymharol Arsylwadol Byd-Eang.
- Dilysrwydd, Dibynadwyedd, ac Ymatebolrwydd Cynnwys a Lluniad yr Holiadur Enyniad Arthritis Rhiwmatoid: Adroddiad Gweithdy OMERACT 2016.
- Diogelwch ac Imiwnogenedd y Brechiad Zoster Byw mewn Cleifion sydd ag Arthritis Rhiwmatoid Cyn Dechrau Tofacitinib: ap-dreial Cam IIH.
- Tocilizumab isgroenol mewn arthritis rhiwmatoid: canfyddiadau o’r rhaglen astudiaeth fframwaith cyffredin cam 4 TOZURA a gynhaliwyd mewn 22 gwlad
